GO THERAPEUTICS INC has a total of 13 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are WUXI BIOLOGICS IRELAND LTD, BIOND BIOLOGICS LTD and PROGASTRINE ET CANCERS S A R L.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | White Thayer | 9 |
#2 | Wandall Hans H | 2 |
#3 | Wandall Hans | 2 |
#4 | Mandel Ulla | 2 |
#5 | Clausen Henrik | 2 |
#6 | Vad Pedersen Johannes Wirenfeldt | 2 |
#7 | Bennett Eric Paul | 2 |
#8 | Thayer White | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020006449A1 | Anti-glyc0-muc1 antibodies and their uses | |
US2019119400A1 | Anti-glyco-muc1 antibodies and their uses | |
KR20200067885A | Anti-glyco-MUC1 antibodies and uses thereof | |
US2017322219A1 | Tn-MUC4 binding polypeptides and uses thereof |